Ciclofilin Pharmaceuticals Overview

  • Founded

  • 2014

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 5

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Ciclofilin Pharmaceuticals General Information

Description

Developer of hepatitis B virus medicine. The company discover and develops treatment and medicine for hepatitis B and C virus that include cyclophilin inhibitors drug.

Contact Information

Website
www.ciclofilin.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Hepion Pharmaceuticals
Primary Office
  • 201, 12707 High Bluff Drive
  • Del Mar
  • San Diego, CA 92130
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ciclofilin Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ciclofilin Pharmaceuticals‘s full profile, request access.

Request a free trial

Ciclofilin Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial